check_circleStudy Completed
Prevention of venous thromboembolism after MOS
Bayer Identifier:
12571
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
EU CT Number:
Not Available
BAY59-7939, ER, Prototype IV
Trial purpose
Please see attached Study Results Summary below
Key Participants Requirements
Sex
N/AAge
18 - 55 YearsTrial summary
Enrollment Goal
N/ATrial Dates
November 2010 - January 2011Phase
N/ACould I Receive a placebo
N/AProducts
Xarelto (Rivaroxaban, BAY59-7939)Accepts Healthy Volunteer
N/AWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Bayer HealthCare | Wuppertal, 42096, Germany |
Trial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A